Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

PF-06821497 is an enhancer of zeste homolog 2 (EZH2) inhibitor (Ki = <0.1 nM for EZH2Y641N).1 It is selective for EZH2 over a panel of 14 methyltransferases, 40 kinases, and 79 additional targets at 10 µM but does bind to EZH1 (Ki = 70 nM). PF-06821497 reduces trimethylation of lysine 27 on histone H3 (H3K27Me3) in, and the proliferation of, Karpas-422 non-Hodgkin lymphoma cells, which endogenously express EZH2Y641N (IC50s = 4 and 6 nM, respectively). In vivo, PF-06821497 (100 mg/kg, s.c.) induces tumor regression in a Karpas-422 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Optimization of orally bioavailable enhancer of zeste homolog 2 (EZH2) inhibitors using ligand and property-